Latest News for: squibb
Edit
Times Argus
24 Feb 2026
Bristol Myers Squibb to Participate in the TD Cowen 46th Annual Health Care Conference
Times Argus
24 Feb 2026
Edit
The Huntsville Item
24 Feb 2026
Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in ...
The Huntsville Item
24 Feb 2026
Edit
Bristol Myers Squibb Announces Positive Top-Line Results from Registrational Phase 2 Study of Luspatercept in Adults with Alpha (α)-Thalassemia
Pharmiweb 23 Feb 2026
Edit
Evinova Announces Strategic Collaborations with Astellas, AstraZeneca and Bristol Myers Squibb Advancing Its AI-Native Platform ...
Business Wire 18 Feb 2026
BAAR, Switzerland--(BUSINESS WIRE)--Evinova announces strategic collaborations with Astellas, AstraZeneca and Bristol Myers Squibb advancing its AI-native platform ... .
Edit
The Joplin Globe
17 Feb 2026
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in ...
The Joplin Globe
17 Feb 2026
Edit
U.S. Food and Drug Administration Accepts Bristol Myers Squibb's New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma
Pharmiweb 17 Feb 2026
Edit
Bristol Myers Squibb to be Inaugural Partner for Life Science Cares National Campaign to Advance Health Equity and Fight Food Insecurity (Bristol-Myers Squibb Company)
Public Technologies 12 Feb 2026
(PRINCETON, N.J., February 12, 2026) - Bristol Myers Squibb (NYSE ... As an inaugural partner, Bristol Myers Squibb will commit $5 million, underscoring its leadership in advancing health equity and reducing barriers to care ... About Bristol Myers Squibb.
Edit
Annual Report for Fiscal Year Ending December 31, 2025 (Form 10-K) (Bristol-Myers Squibb Company)
Public Technologies 11 Feb 2026
Edit
Arthralgia Market: Accelerating Growth and Pipeline Impact – DelveInsight | Sun Pharma, Bristol-Myers Squibb, UCB ...
GetNews 10 Feb 2026
Sun Pharma, Bristol-Myers Squibb, UCB Biopharma, Affibody AB, Sun Pharmaceutical Industries, Ventyx Biosciences, Aclaris Therapeutics, AbbVie, Novartis, Janssen Research & Development, LLC, MoonLake Immunotherapeutics AG, and others.
Edit
Bladder Cancer Market: Rapid Increment Driven by Innovation by 2034 – DelveInsight | Bristol-Myers Squibb ...
GetNews 10 Feb 2026
The Key Bladder Cancer Companies in the market include - Bristol-Myers Squibb Company, GlaxoSmithKline PLC., Johnson & Johnson (Janssen Pharmaceutical), F ... Bristol-Myers Squibb ... BristolMyers Squibb.
Edit
The Galveston Daily News
09 Feb 2026
Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence
The Galveston Daily News
09 Feb 2026
Edit
The Galveston Daily News
05 Feb 2026
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2025
The Galveston Daily News
05 Feb 2026
Edit
Bristol Myers Squibb Revenue Ticks Up on Immuno-Oncology Growth
Wall Street Journal 05 Feb 2026
Bristol Myers Squibb reported higher fourth-quarter revenue as growth in sales of its immuno-oncology treatments helped to offset a decline in revenue for some of its older drugs ... .
Edit
Bristol Myers Squibb CEO: Richest product pipeline we've had in the last decade
CNBC 05 Feb 2026
Chris Boerner, Bristol Myers Squibb CEO, joins 'Power Lunch' to discuss the company's quarterly earnings results, the drug pipeline and much more ... .
Edit
Bristol-Myers Squibb (NYSE:BMY) Reports Strong Q4 CY2025
The Call 05 Feb 2026
Biopharmaceutical company Bristol Myers Squibb (NYSE ... Is now the time to buy Bristol-Myers Squibb? Find out by accessing our full research report, it’s free. Bristol-Myers Squibb (BMY) Q4 CY2025 Highlights..
- 1
- 2
- Next page »